GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » PE Ratio (TTM)

NeueHealth (NeueHealth) PE Ratio (TTM) : At Loss (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NeueHealth PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-05-27), NeueHealth's share price is $5.95. NeueHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-130.59. Therefore, NeueHealth's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for NeueHealth's PE Ratio (TTM) or its related term are showing as below:

NEUE' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: At Loss   Max: At Loss
Current: At Loss



NEUE's PE Ratio (TTM) is ranked worse than
100% of 13 companies
in the Healthcare Plans industry
Industry Median: 18.02 vs NEUE: At Loss

NeueHealth's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-3.53. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-130.59.

As of today (2024-05-27), NeueHealth's share price is $5.95. NeueHealth's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.69. Therefore, NeueHealth's PE Ratio without NRI for today is At Loss.

NeueHealth's EPS without NRI for the three months ended in Mar. 2024 was $-5.91. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.69.

During the past 3 years, the average EPS without NRI Growth Rate was 11.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -25.20% per year.

During the past 6 years, NeueHealth's highest 3-Year average EPS without NRI Growth Rate was 11.90% per year. The lowest was -102.10% per year. And the median was -53.50% per year.

NeueHealth's EPS (Basic) for the three months ended in Mar. 2024 was $-3.53. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-130.59.


NeueHealth PE Ratio (TTM) Historical Data

The historical data trend for NeueHealth's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth PE Ratio (TTM) Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
Get a 7-Day Free Trial N/A N/A At Loss At Loss At Loss

NeueHealth Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of NeueHealth's PE Ratio (TTM)

For the Healthcare Plans subindustry, NeueHealth's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeueHealth's PE Ratio (TTM) Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where NeueHealth's PE Ratio (TTM) falls into.



NeueHealth PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

NeueHealth's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=5.95/-130.590
=At Loss

NeueHealth's Share Price of today is $5.95.
NeueHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-130.59.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


NeueHealth  (NYSE:NEUE) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


NeueHealth PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of NeueHealth's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


NeueHealth (NeueHealth) Business Description

Traded in Other Exchanges
N/A
Address
8000 Norman Center Drive, Suite 900, Minneapolis, MN, USA, 55437
Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.
Executives
Mikan George Lawrence Iii director, officer: CEO and President 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jay Matushak officer: Chief Financial Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey S Cook officer: CEO, NeueHealth C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey J Scherman officer: Chief Accounting Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith officer: CFO & CAO TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Jeff Michael Craig officer: GC & CORPORATE SECRETARY C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Manuel Kadre director 2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt director GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p. 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson officer: CEO, Bright HealthCare C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437

NeueHealth (NeueHealth) Headlines

From GuruFocus

Bright Health Group Appoints Jay Matushak as Chief Financial Officer

By Business Wire Business Wire 05-03-2023

Bright Health Group Receives Continued Listing Standard Notice from NYSE

By Business Wire Business Wire 12-12-2022